Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer

Clinical trial NCT00390806 · COMPLETED

Trial details

NCT number: NCT00390806
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Cancer, Non-Small Cell

Start date: 2006-12-01
Primary completion: 2012-07-01
Enrollment: 472

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.